Tapewire

Nasdaq · USD

NSPR

InspireMD, Inc.

Export transactions ↓
Tapewire entity
7318
SEC CIK
0001433607
Parsed reports
164

Last 12 months

Inside the activity.

18 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202540
Jan 202609
Feb 202602
Mar 202600
Apr 202600
May 2026131
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 10, 2021 Filed Nov 12, 2021 21:05 UTC GrantCommon Stock 17,248 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-028170 · ownership.xml · nonDerivative · entry 1

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,336

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service.

Read SEC document
November 10, 2021 Filed Nov 12, 2021 21:05 UTC
Shore CraigCFO and CAO
GrantOptions to purchase common stock (right to buy) · Derivative 24,326 $0.00 Strike: $4.09 $0.00
Disclosure

SEC source: 0001493152-21-028168 · ownership.xml · derivative · entry 2

Shore Craig · CIK 0001517387 · CFO and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,326

Underlying: Common Stock · 24,326 shares

Expires 2031-11-10

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service.

Read SEC document
November 10, 2021 Filed Nov 12, 2021 21:05 UTC
Shore CraigCFO and CAO
GrantCommon Stock 72,978 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-028168 · ownership.xml · nonDerivative · entry 1

Shore Craig · CIK 0001517387 · CFO and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,639

F1 · shares: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service.

Read SEC document
November 10, 2021 Filed Jan 6, 2022 21:05 UTC Amendment
Shore CraigCFO and CAO
GrantOptions to purchase common stock (right to buy) · Derivative 24,326 $0.00 Strike: $4.09 $0.00
Disclosure

SEC source: 0001493152-22-000554 · ownership.xml · derivative · entry 2

Shore Craig · CIK 0001517387 · CFO and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,326

Underlying: Common Stock · 24,326 shares

Expires 2031-11-10

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service.

Read SEC document
November 10, 2021 Filed Jan 6, 2022 21:05 UTC Amendment
Shore CraigCFO and CAO
GrantCommon Stock 72,978 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000554 · ownership.xml · nonDerivative · entry 1

Shore Craig · CIK 0001517387 · CFO and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,639

F1 · shares: These shares of common stock vest and become exercisable in three equal annual installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service.

Read SEC document
October 13, 2021 Filed Oct 14, 2021 21:00 UTC GrantOptions to purchase common stock (right to buy) · Derivative 5,749 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001493152-21-025452 · ownership.xml · derivative · entry 2

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,749

Underlying: Common Stock · 5,749 shares

Expires 2031-10-13

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024 subject to the Reporting Person's continued service.

Read SEC document
October 13, 2021 Filed Oct 14, 2021 21:00 UTC GrantCommon Stock 17,248 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-025452 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,371

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.

Read SEC document
October 13, 2021 Filed Oct 14, 2021 17:01 UTC GrantOptions to purchase common stock (right to buy) · Derivative 5,749 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001493152-21-025453 · ownership.xml · derivative · entry 2

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,749

Underlying: Common Stock · 5,749 shares

Expires 2031-10-13

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.

Read SEC document
October 13, 2021 Filed Oct 14, 2021 17:01 UTC GrantCommon Stock 17,248 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-025453 · ownership.xml · nonDerivative · entry 1

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,784

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.

Read SEC document
October 13, 2021 Filed Oct 14, 2021 21:01 UTC
Slosman MarvinDirector · CEO and President
GrantOptions to purchase common stock (right to buy) · Derivative 48,855 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001493152-21-025454 · ownership.xml · derivative · entry 2

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,855

Underlying: Common Stock · 48,855 shares

Expires 2031-10-13

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.

Read SEC document
October 13, 2021 Filed Oct 14, 2021 21:01 UTC
Slosman MarvinDirector · CEO and President
GrantRestricted Stock Units 146,567 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-025454 · ownership.xml · nonDerivative · entry 1

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,470

F1 · security: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.

Read SEC document
October 13, 2021 Filed Oct 14, 2021 21:03 UTC GrantOptions to purchase common stock (right to buy) · Derivative 5,749 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001493152-21-025456 · ownership.xml · derivative · entry 2

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,749

Underlying: Common Stock · 5,749 shares

Expires 2031-10-13

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.

Read SEC document
October 13, 2021 Filed Oct 14, 2021 21:03 UTC GrantCommon Stock 17,248 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-025456 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,355

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.

Read SEC document
October 13, 2021 Filed Oct 14, 2021 21:01 UTC
Stuka PaulDirector
GrantOptions to purchase common stock (right to buy) · Derivative 8,693 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001493152-21-025455 · ownership.xml · derivative · entry 2

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,693

Underlying: Common Stock · 8,693 shares

Expires 2031-10-13

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.

Read SEC document
October 13, 2021 Filed Oct 14, 2021 21:01 UTC
Stuka PaulDirector
GrantCommon Stock 26,079 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-025455 · ownership.xml · nonDerivative · entry 1

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,320

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.

Read SEC document
October 13, 2021 Filed Oct 14, 2021 21:00 UTC GrantOptions to purchase common stock (right to buy) · Derivative 5,749 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001493152-21-025451 · ownership.xml · derivative · entry 2

Rogers Campbell · CIK 0001585724 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,749

Underlying: Common Stock · 5,749 shares

Expires 2031-10-13

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.

Read SEC document
October 13, 2021 Filed Oct 14, 2021 21:00 UTC GrantCommon Stock 17,248 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-025451 · ownership.xml · nonDerivative · entry 1

Rogers Campbell · CIK 0001585724 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,960

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.

Read SEC document
August 25, 2021 Filed Aug 26, 2021 21:00 UTC PurchaseCommon Stock 22,249 $4.19 $93,245.56
Disclosure

SEC source: 0001493152-21-021349 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,123

F1 · balance_after: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.219 to $4.085, inclusive. The Reporting Person undertakes to provide to InspireMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

F3 · balance_after: All share amounts reflect the Company's reverse stock split effectuated on April 26, 2021.

Read SEC document
May 10, 2021 Filed May 12, 2021 06:15 UTC GrantOption to Purchase Common Stock · Derivative 3,512 $0.00 Strike: $4.74 $0.00
Disclosure

SEC source: 0001493152-21-011070 · ownership.xml · derivative · entry 2

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,512

Underlying: Common Stock · 3,512 shares

Expires 2031-05-10

F2 · security: The options reported in this row vest and become exercisable in three equal installments, with 1/3 vesting on each of May 10, 2022, May 10, 2023 and May 10, 2024, subject to the Reporting Person's continued service.

F2 · derivative.exercise_date: The options reported in this row vest and become exercisable in three equal installments, with 1/3 vesting on each of May 10, 2022, May 10, 2023 and May 10, 2024, subject to the Reporting Person's continued service.

Read SEC document
May 10, 2021 Filed May 12, 2021 06:15 UTC GrantCommon Stock 10,536 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-011070 · ownership.xml · nonDerivative · entry 1

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,536

F1 · security: The shares of common stock reported in this row represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 10, 2022, May 10, 2023 and May 10, 2024, subject to the Reporting Person's continued service.

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 10, 2022, May 10, 2023 and May 10, 2024, subject to the Reporting Person's continued service.

Read SEC document
April 19, 2021 Filed Apr 21, 2021 10:20 UTC GrantOption to Purchase Common Stock · Derivative 75,000 $0.00 Strike: $0.46 $0.00
Disclosure

SEC source: 0001493152-21-009317 · ownership.xml · derivative · entry 3

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,650

Underlying: Common Stock · 75,000 shares

Expires 2031-04-19

F2 · derivative.exercise_date: These options vest and become exercisable in three equal installments, with 1/3 vesting on each of April 19, 2022, April 19, 2023 and April 19, 2024, subject to the Reporting Person's continued service.

Read SEC document
April 19, 2021 Filed Apr 21, 2021 10:20 UTC
Slosman MarvinDirector · CEO and President
GrantOption to Purchase Common Stock · Derivative 600,000 $0.00 Strike: $0.46 $0.00
Disclosure

SEC source: 0001493152-21-009319 · ownership.xml · derivative · entry 3

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,052,556

Underlying: Common Stock · 600,000 shares

Expires 2031-04-19

F2 · derivative.exercise_date: These options vest and become exercisable in three equal installments, with 1/3 vesting on each of April 19, 2022, April 19, 2023 and April 19, 2024, subject to the Reporting Person's continued service.

Read SEC document
April 19, 2021 Filed Apr 21, 2021 10:20 UTC
Shore CraigCFO and CAO
GrantOption to Purchase Common Stock · Derivative 100,000 $0.00 Strike: $0.46 $0.00
Disclosure

SEC source: 0001493152-21-009318 · ownership.xml · derivative · entry 2

Shore Craig · CIK 0001517387 · CFO and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 326,289

Underlying: Common Stock · 100,000 shares

Expires 2031-04-19

F2 · derivative.exercise_date: These options vest and become exercisable in three equal installments, with 1/3 vesting on each of April 19, 2022, April 19, 2023 and April 19, 2024, subject to the Reporting Person's continued service.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 12:11 UTC PurchaseWarrants · Derivative 120,965 $0.62 Strike: $0.68 $74,998.30
Disclosure

SEC source: 0001493152-21-003204 · ownership.xml · derivative · entry 2

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,188

Underlying: Common Stock · 120,965 shares

Expires 2026-02-08

F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 241,930 shares of common stock and warrants to purchase 120,965 shares of common stock together, as part of 241,930 units, at a purchase price of $0.62 per unit.

F1 · derivative.underlying_shares: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 241,930 shares of common stock and warrants to purchase 120,965 shares of common stock together, as part of 241,930 units, at a purchase price of $0.62 per unit.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 12:11 UTC PurchaseCommon Stock 241,930 $0.62 $149,996.60
Disclosure

SEC source: 0001493152-21-003204 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 703,103

F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 241,930 shares of common stock and warrants to purchase 120,965 shares of common stock together, as part of 241,930 units, at a purchase price of $0.62 per unit.

F1 · balance_after: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 241,930 shares of common stock and warrants to purchase 120,965 shares of common stock together, as part of 241,930 units, at a purchase price of $0.62 per unit.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 12:13 UTC
Slosman MarvinDirector · CEO and President
PurchaseWarrants · Derivative 20,160 $0.62 Strike: $0.68 $12,499.20
Disclosure

SEC source: 0001493152-21-003209 · ownership.xml · derivative · entry 2

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,710

Underlying: Common stock · 20,160 shares

Expires 2026-02-08

F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 40,320 shares of common stock and warrants to purchase 20,160 shares of common stock together, as part of 40,320 units, at a purchase price of $0.62 per unit.

F1 · derivative.underlying_shares: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 40,320 shares of common stock and warrants to purchase 20,160 shares of common stock together, as part of 40,320 units, at a purchase price of $0.62 per unit.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 12:13 UTC
Slosman MarvinDirector · CEO and President
PurchaseCommon Stock 40,320 $0.62 $24,998.40
Disclosure

SEC source: 0001493152-21-003209 · ownership.xml · nonDerivative · entry 1

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,453,538

F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 40,320 shares of common stock and warrants to purchase 20,160 shares of common stock together, as part of 40,320 units, at a purchase price of $0.62 per unit.

F1 · balance_after: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 40,320 shares of common stock and warrants to purchase 20,160 shares of common stock together, as part of 40,320 units, at a purchase price of $0.62 per unit.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 12:13 UTC PurchaseWarrants · Derivative 60,480 $0.62 Strike: $0.68 $37,497.60
Disclosure

SEC source: 0001493152-21-003208 · ownership.xml · derivative · entry 2

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,480

Underlying: Common Stock · 60,480 shares

Expires 2026-02-08

F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 120,960 shares of common stock and warrants to purchase 60,480 shares of common stock together, as part of 120,960 units, at a purchase price of $0.62 per unit.

F1 · derivative.underlying_shares: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 120,960 shares of common stock and warrants to purchase 60,480 shares of common stock together, as part of 120,960 units, at a purchase price of $0.62 per unit.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 12:13 UTC PurchaseCommon Stock 120,960 $0.62 $74,995.20
Disclosure

SEC source: 0001493152-21-003208 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,593

F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 120,960 shares of common stock and warrants to purchase 60,480 shares of common stock together, as part of 120,960 units, at a purchase price of $0.62 per unit.

F1 · balance_after: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 120,960 shares of common stock and warrants to purchase 60,480 shares of common stock together, as part of 120,960 units, at a purchase price of $0.62 per unit.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 12:11 UTC PurchaseWarrants · Derivative 40,320 $0.62 Strike: $0.68 $24,998.40
Disclosure

SEC source: 0001493152-21-003205 · ownership.xml · derivative · entry 2

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,320

Underlying: Common Stock · 40,320 shares

Expires 2026-02-08

F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 80,640 shares of common stock and warrants to purchase 40,320 shares of common stock together, as part of 80,640 units, at a purchase price of $0.62 per unit.

F1 · derivative.underlying_shares: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 80,640 shares of common stock and warrants to purchase 40,320 shares of common stock together, as part of 80,640 units, at a purchase price of $0.62 per unit.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 12:11 UTC PurchaseCommon Stock 80,640 $0.62 $49,996.80
Disclosure

SEC source: 0001493152-21-003205 · ownership.xml · nonDerivative · entry 1

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,275

F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 80,640 shares of common stock and warrants to purchase 40,320 shares of common stock together, as part of 80,640 units, at a purchase price of $0.62 per unit.

F1 · balance_after: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 80,640 shares of common stock and warrants to purchase 40,320 shares of common stock together, as part of 80,640 units, at a purchase price of $0.62 per unit.

Read SEC document
October 16, 2020 Filed Oct 19, 2020 14:18 UTC PurchaseWarrants · Derivative 222,223 $0.45 Strike: $0.50 $100,000.35
Disclosure

SEC source: 0001493152-20-019601 · ownership.xml · derivative · entry 2

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,223

Underlying: Common Stock · 222,223 shares

Expires 2025-10-16

F1 · derivative.underlying_shares: The Reporting Person purchased, in a private placement transaction, 222,223 shares of common stock and 222,223 warrants to purchase common stock together, as part of 222,223 units, at a purchase price of $0.45 per unit.

Read SEC document
October 16, 2020 Filed Oct 19, 2020 14:18 UTC PurchaseCommon Stock 222,223 $0.45 $100,000.35
Disclosure

SEC source: 0001493152-20-019601 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 461,173

F1 · shares: The Reporting Person purchased, in a private placement transaction, 222,223 shares of common stock and 222,223 warrants to purchase common stock together, as part of 222,223 units, at a purchase price of $0.45 per unit.

F2 · balance_after: 238,950 of these shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 12, 2021, October 12, 2022 and October 12, 2023, subject to the Reporting Person's continued service.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 16:59 UTC
Slosman MarvinDirector · CEO and President
GrantOptions (right to buy) · Derivative 391,762 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001493152-20-017128 · ownership.xml · derivative · entry 3

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 452,556

Underlying: Common stock · 391,762 shares

Expires 2030-08-31

F4 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 16:59 UTC
Slosman MarvinDirector · CEO and President
GrantCommon Stock 1,175,287 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-017128 · ownership.xml · nonDerivative · entry 1

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,413,218

F1 · shares: These shares of common stock represent restricted stock units ("RSUs"), which each vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

F2 · balance_after: Consists of (i) an aggregate of 1,357,668 shares of common stock represented by RSUs, which vest over time, subject to the Reporting Person's continued service, and (ii) 55,550 shares of common stock.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 17:02 UTC
Shore CraigCFO AND CAO
GrantOptions to purchase common stock (right to buy) · Derivative 226,278 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001493152-20-017131 · ownership.xml · derivative · entry 2

Shore Craig · CIK 0001517387 · CFO AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,289

Underlying: Common Stock · 226,278 shares

Expires 2030-08-31

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 17:02 UTC
Shore CraigCFO AND CAO
GrantCommon Stock 678,834 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-017131 · ownership.xml · nonDerivative · entry 1

Shore Craig · CIK 0001517387 · CFO AND CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 684,849

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 17:00 UTC GrantOptions to purchase common stock (right to buy) · Derivative 52,678 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001493152-20-017129 · ownership.xml · derivative · entry 2

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,692

Underlying: Common Stock · 52,678 shares

Expires 2030-08-31

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 17:00 UTC GrantCommon Stock 158,033 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-017129 · ownership.xml · nonDerivative · entry 1

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,635

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 16:58 UTC GrantOptions to purchase common stock (right to buy) · Derivative 52,678 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001493152-20-017127 · ownership.xml · derivative · entry 2

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,686

Underlying: Common Stock · 52,678 shares

Expires 2030-08-31

F3 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 16:58 UTC GrantCommon Stock 158,033 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-017127 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,633

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

F2 · balance_after: Consists of (i) an aggregate of 160,633 shares of common stock represented by restricted stock, which have vested or vest over time, subject to the Reporting Person's continued service, and (ii) 50,000 shares of common stock.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 16:57 UTC
Stuka PaulDirector
GrantOptions to purchase common stock (right to buy) · Derivative 79,650 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001493152-20-017126 · ownership.xml · derivative · entry 2

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,678

Underlying: Common Stock · 79,650 shares

Expires 2030-08-31

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 16:57 UTC
Stuka PaulDirector
GrantCommon Stock 238,950 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-017126 · ownership.xml · nonDerivative · entry 1

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,606

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 16:55 UTC GrantOptions to purchase common stock (right to buy) · Derivative 52,678 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001493152-20-017125 · ownership.xml · derivative · entry 2

Rogers Campbell · CIK 0001585724 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,692

Underlying: Common Stock · 52,678 shares

Expires 2030-08-31

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 16:55 UTC GrantCommon Stock 158,033 $0.00 $0.00
Disclosure

SEC source: 0001493152-20-017125 · ownership.xml · nonDerivative · entry 1

Rogers Campbell · CIK 0001585724 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,635

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

Read SEC document
August 31, 2020 Filed Feb 10, 2021 12:13 UTC
Slosman MarvinDirector · CEO and President
GrantOptions (right to buy) · Derivative 391,762 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001493152-21-003209 · ownership.xml · derivative · entry 3

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 452,556

Underlying: Common stock · 391,762 shares

Expires 2030-08-31

F2 · security: The Reporting Person has not engaged in any reportable transactions with respect to these derivative securities of the Issuer and is including his ownership of these securities for informational purposes only in this Form 4.

F3 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

Read SEC document
August 31, 2020 Filed Feb 10, 2021 12:11 UTC GrantOptions to purchase common stock (right to buy) · Derivative 52,678 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001493152-21-003205 · ownership.xml · derivative · entry 3

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,692

Underlying: Common Stock · 52,678 shares

Expires 2030-08-31

F2 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

F3 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 17:30 UTC
Slosman MarvinDirector · CEO and President
PurchaseWarrants · Derivative 55,550 $0.45 Strike: $0.50 $24,997.50
Disclosure

SEC source: 0001493152-20-010852 · ownership.xml · derivative · entry 2

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,550

Underlying: Common Stock · 55,550 shares

Expires 2025-06-02

F1 · derivative.underlying_shares: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 55,550 shares of common stock and 55,000 warrants to purchase common stock together, as part of 55,000 units, at a purchase price of $0.45 per unit.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 17:30 UTC
Slosman MarvinDirector · CEO and President
PurchaseCommon Stock 55,550 $0.45 $24,997.50
Disclosure

SEC source: 0001493152-20-010852 · ownership.xml · nonDerivative · entry 1

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,931

F1 · shares: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 55,550 shares of common stock and 55,000 warrants to purchase common stock together, as part of 55,000 units, at a purchase price of $0.45 per unit.

F2 · balance_after: 182,381 of these shares of common stock represent restricted stock units ("RSUs"), which vest in three equal annual installments, with 1/3 vesting on each of January 2, 2021, January 2, 2022 and January 2, 2023, subject to the Reporting Person's continued service.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 15:59 UTC PurchaseCommon Stock 50,000 $0.42 $20,750.00
Disclosure

SEC source: 0001493152-20-010629 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,600

F1 · balance_after: 2,600 of these shares of common stock represent an award of restricted stock units ("RSUs"), which was previously reported by the Reporting Person, as 130,000 shares/RSUs, but which has been reduced to 2,600 RSUs due to a reverse split of the Issuer's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.